Doctolib acquires Medicus and reveals £100m UK investment plans

By Published On: May 6, 2026Last Updated: May 6, 2026
Doctolib acquires Medicus and reveals £100m UK investment plans

Doctolib has bought Medicus and plans to invest more than £100m in the UK after sealing the deal for the London-based GP software firm.

The deal, for an undisclosed amount, will see Doctolib deliver combined technology, AI and services to the clinical and administrative teams of GP practices across the country.

Its plans include hiring 150 people and establishing a full R&D centre in London to drive innovation in primary care.

Medicus will continue to operate with founder and chief executive Emile Axelrad at the helm, and keep its UK-based team in place.

Axelrad said: “This is an important step for Medicus, for the GP practices we support and for the future of primary care in the UK.

He added: “By joining forces with Doctolib, we will strengthen the platform, accelerate innovation and give practices access to even greater product and service capabilities, while preserving the quality, proximity and understanding they already value from our team.”

 “Together, as a British team, we want to raise the standard for GP technology across the UK.”

Doctolib, which claims to have a suite of AI assistants, currently serves more than 40,000 GPs, 500,000 total health professionals and 1,000 hospitals across Europe.

The firm introduced the first new GP clinical software system in the NHS in 25 years after it was developed through NHS England’s Tech Innovation Framework.

The platform is designed to meet national requirements and integrate with key health systems, including the NHS App.

Stanislas Niox-Chateau, co-founder and chief executive of Doctolib, said: “Medicus has built an impressive product and team for UK general practices.

“By joining forces, we are becoming one team with one ambition: give GP practices in the UK the best technology, AI and services to simplify work, improve coordination and help professionals spend more time caring for patients. We are making a long-term commitment to the UK.

“We plan to invest more than £100m in the UK over the coming years, hire 150 people in London, establish a dedicated R&D centre, and bring the full power of our expertise, including our AI clinical lab, to support innovation in NHS primary care.”

Why contract management must be the engine for NHS delivery
Post